Abstract:Pseudomonas aeruginosa is a major opportunistic pathogen and one of the leading bacterial species causing health care-associated infections. Carbapenems are the most effective antimicrobial agents for the treatment of severe infections caused by P. aeruginosa . However, our recent surveillance demonstrated that the prevalence of carbapenem-resistant P. aeruginosa (CRPA) reached 38.67% in Zhejiang, China. By analyzing CRPA isolates collected from patients from 2006 to 2018, we found that 33% of CRPA isolates carried the gene bla KPC-2 , which conferred high-level resistance to carbapenems and other β-lactams. In particular, a CRPA clone, ST463 (sequence type 463), emerged and has become the predominant CRPA clone among the population. Genome sequencing demonstrated that ST463 expansion was associated with plasmid-borne bla KPC-2 . The mobile element flanking bla KPC-2 , the type IV secretion system, and the successful expansion of clone ST463 might have further favored bla KPC-2 spread in P. aeruginosa . Molecular clock analysis dated the emergence of clone ST463 to around 2007. Genome-wide association analysis showed that 567 genes were associated with clone ST463, including several known virulence genes related to the biosynthesis of lipooligosaccharide (LOS) O-antigens and exotoxin. These findings indicate that ST463 is expanding with plasmid-borne bla KPC-2 and virulence-related genes in nosocomial infections, and close surveillance should be undertaken in the future. IMPORTANCE Health care-associated infections, also known as nosocomial infections, are the most frequent adverse events in health care delivery worldwide, causing high rates of morbidity and mortality and high health care costs. Pseudomonas aeruginosa is one of the leading bacterial species causing health care-associated infections. Carbapenems are the most effective antimicrobial agents for the treatment of its severe infections. However, the prevalence of carbapenem-resistant P. aeruginosa (CRPA) has been increasing rapidly in recent years, and our surveillance demonstrated that the prevalence of CRPA reached 38.67% in Zhejiang, China. Genome sequencing of CRPA isolates over a decade showed that a CRPA clone (ST463) emerged recently. The clone is highly resistant to β-lactams, including carbapenems, and fluoroquinolones. Genome-wide association analysis showed that the clone expanded with virulence-related genes and the plasmid-borne carbapenem-resistant gene bla KPC-2 . These findings are of significant public health importance, as the information will facilitate the control and minimization of CRPA nosocomial infections.

Emergence of Kpc-2-Producing Pseudomonas Aeruginosa Sequence Type 463 Isolates in Hangzhou, China

Emergence of Klebsiella Pneumoniae Carbapenemase-Producing Escherichia Coli Sequence Type 131 in Hangzhou, China

Emergence of Escherichia Coli Sequence Type 131 Isolates Producing KPC-2 Carbapenemase in China.

St11, the Dominant Clone of Kpc-Producing Klebsiella Pneumoniae in China

Outbreak of Klebsiella Pneumoniae Carbapenemase 2-Producing K. Pneumoniae with High Qnr Prevalence in a Chinese Hospital.

Emergence of carbapenem-resistant Serotype K1 hypervirulent Klebsiella pneumoniae (hvKP) strains in China.

Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a chinese hospital

Transmission Dynamics of Carbapenem-Resistant Klebsiella Pneumoniae Sequence Type 11 Strains Carrying Capsular Loci KL64 and Rmpa/rmpa2 Genes

Emergence of Proteus Mirabilis Harboring Blakpc-2 and Qnrd in a Chinese Hospital

Dissemination of extensively drug-resistant and KPC-2 producing Klebsiella pneumoniae isolated from bloodstream infections

Emergence and clonal dissemination of KPC-3-producing Pseudomonas aeruginosa in China with an IncP-2 megaplasmid

Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne blaKPC-2 and Virulence-Related Genes

Plasmid-Mediated Kpc-2 in A Klebsiella Pneumoniae Isolate from China

Emerging and Re-Emerging KPC-producing Hypervirulent Pseudomonas Aeruginosa ST697 and ST463 Between 2010 and 2021

Detection of a Common Plasmid Carrying Blakpc-2 in Enterobacteriaceae Isolates from Distinct Cities in China.

Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020–2022

High Prevalence of Esbl-Producing Klebsiella Pneumoniae Causing Community-Onset Infections in China

bla KPC and rmtB on a single plasmid in Enterobacter amnigenus and Klebsiella pneumoniae isolates from the same patient

Novel Genetic Environment of the Carbapenem-Hydrolyzing Beta-Lactamase Kpc-2 among Enterobacteriaceae in China

Epidemic of Klebsiella pneumoniae ST11 Clone Coproducing KPC-2 and 16S rRNA Methylase RmtB in a Chinese University Hospital

Emergence of Bla KPC-33-Harboring Hypervirulent ST463 Pseudomonas Aeruginosacausing Fatal Infections in China